Chinese Clinical Oncology

• 论著 • Previous Articles     Next Articles

Expressions of CD109,HMW-CK,vimentin,p63 and AR in basallike breast cancer

SHI Peng-ju,CAI Hai-feng,NIU Feng-ling,ZHAO Yan-hui,ZHAO Gang   

  1. General Surgery,the Second Hospital of Tangshan,Tangshan 063000,China
  • Received:2012-04-28 Revised:2012-08-28 Online:2012-10-31 Published:2012-10-31
  • Contact: ZHAO Gang

Abstract: ObjectiveTo investigate the expressions and significance of CD109, high molecular weight cytokeratin(HMW-CK),vimentin,p63 and antrogen receptor(AR) in basal-like breast cancer(BLBC). Methods ER and PR-negative and CK5/6 and/or EGFR-postive expression was defined as BLBC. Immunohistochemical method was used to determine the expressions of CD109,HMW-CK,vimentin,p63 and AR in 86 cases of BLBC,compared with 57 cases of luminal type and 33 cases of HER-2 over-expressed breast cancer. Results The positive rates of CD109 were 61.6%,8.8% and 9.1% in BLBC,luminal type and HER-2 over-expressed breast cancer,while HMW-CK were 90.7%,26.3% and 33.3%,and AR were 31.4%,71.9% and 42.4%. There was significant difference among them(P<0.01). The positive rates of vimentin was 57.0%,42.1% and 51.5%,and p63 were 31.4%,29.8% and 24.2% respectively. The difference was not significant among them(P>0.05). The expression of CD109,HMW-CK,vimentin and p63 were not correlated to age,tumor size,histological grade and lymphadenopathy. AR was correlated to histological grade in BLBC.
Conclusion CD109 and HMW-CK are the specific markers for the diagnosis of BLBC,while vimentin and p63 are not. The lack of AR expression in BLBC is related to invasion of tumor and malignant phenotype.

No related articles found!
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!